Bill Text: IL SB3342 | 2019-2020 | 101st General Assembly | Introduced

---

Bill Title: Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Failed) 2021-01-13 - Session Sine Die [SB3342 Detail]

Download: Illinois-2019-SB3342-Introduced.html

---

101ST GENERAL ASSEMBLY State of Illinois 2019 and 2020 SB3342 Introduced 2/11/2020, by Sen. Laura M. Murphy SYNOPSIS AS INTRODUCED:
30 ILCS 500/25-210 new
Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.
LRB101 20250 RJF 69790 b
FISCAL NOTE ACT MAY APPLY
A BILL FOR
SB3342 LRB101 20250 RJF 69790 b
AN ACT concerning finance.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Procurement Code is amended by
adding Section 25-210 as follows:
(30 ILCS 500/25-210 new)
Sec. 25-210. Generic prescription drug contracting. The
Department of Central Management Services, in consultation
with the Chief Procurement Officer, shall implement and develop
a program to establish a State prescription generic drug label
for the purpose of increasing competition in the generic drug
market and lowering generic drug prices for all purchasers. The
Department shall contract with one or more generic drug
manufacturers to manufacture certain generic drugs on behalf of
the State and participating entities. The Department shall
adopt rules necessary to implement and administer the program
created under this Section.